SynAct Pharma (SYNACT)

Last close As at 15/08/2025

SEK18.56

−0.38 (−2.01%)

Market capitalisation

SEK929m

SynAct Pharma is a clinical-stage biotechnology company focussed on the development of treatments to resolve, rather than inhibit, ongoing inflammatory processes in acute and chronic diseases.

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Jeppe Øvlesen

    CEO

  • Björn Westberg

    CFO

Thematics

thematic

Healthcare

Healthcare-focused trusts: A sector on the mend

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free